Press Releases
Shilpa Biologicals Pvt Ltd signs strategic development partnership with mAbTree Biologics AG for a novel immuno-oncology asset
Basel Switzerland, and Karnataka India: mAbTree Biologics AG has signed an exclusive co-development and commercialization partnership with Shilpa Biologicals Pvt Ltd. (a fully owned subsidiary of Shilpa Medicare Limited)...
Press Releases
Sirio Launches Global Research Institute for Longevity Studies [SIA]
Research Institute to advance nutraceutical product development across four core research areas
SIRIO Pharma (SIRIO) – the global nutraceutical contract development and manufacturing organization (CDMO) – announces...
Press Releases
Shilpa Launches ‘hybrid CDMO’ at DCAT
Shilpa Medicare launches its new full service ‘hybrid’ CDMO at DCAT 2025. The newly formed CDMO will see Shilpa serve both small and large molecules customers...
Press Releases
White Raven, a new Belgian CDMO, obtains GMP certification for its aseptic fill & finish facility with a robotic gloveless workcell for small-batch manufacturing.
White Raven has successfully obtained GMP certification for its state-of-the-art aseptic fill & finish facility.
The facility features Cytiva’s SA25 aseptic filling workcell, a...
Press Releases
CordenPharma Expands Peptide Platform with >€500m Greenfield Facility Construction in the Basel Region of Switzerland
CordenPharma is making a record investment of >€1 billion over the next 3 years in building and / or expanding small, medium, and large peptide manufacturing...
Business & Industry
Thermo Fisher to acquire Solventum’s Purification & Filtration business for US$4.1bn
The Purification & Filtration division manufactures filters and membranes for biopharmaceutical and medical technologies, microelectronics, food and beverage goods, and drinking water. It employs over...
Drug Research
LINDIS Biotech Partners with Celonic for Production and Commercial Supply of Catumaxomab
LINDIS Biotech has received EMA Marketing Authorisation for catumaxomab, making it the only medicine licensed for the targeted and cancer-directed therapy of malignant ascites.
...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.